Post-COVID-19 pneumonia lung fibrosis: a worrisome sequelae in surviving patients

[1] Peter M(2020)Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy Lancet 138 805-815

[2] Athol U(2019)Lung transplantation for idiopathic pulmonary fibrosis Lancet Respir Med 7 271-282

[3] Jenkins RG(2020)For the Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19 J Am Med Assoc 324 603-605

[4] George P(2017)Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities Lancet Respir Med 5 72-84

[5] Patterson C(2014)Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis N Engl J Med 370 2071-2082

[6] Ak R(2014)A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis N Engl J Med 370 2083-2092

[7] Carfì A(2021)Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids Lung India 38 1-105

[8] Bernabei R(2020)Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: A two-center descriptive study Lancet Infect Dis 1473-3099 30434-30435

[9] Landi F(2020)Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan China JAMA Intern Med 180 934-943

[10] King CS(2020)Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis Eur Radiol 4 1-10

[1] Peter M(2020)Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy Lancet 138 805-815

[2] Athol U(2019)Lung transplantation for idiopathic pulmonary fibrosis Lancet Respir Med 7 271-282

[3] Jenkins RG(2020)For the Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19 J Am Med Assoc 324 603-605

[4] George P(2017)Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities Lancet Respir Med 5 72-84

[5] Patterson C(2014)Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis N Engl J Med 370 2071-2082

[6] Ak R(2014)A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis N Engl J Med 370 2083-2092

[7] Carfì A(2021)Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids Lung India 38 1-105

[8] Bernabei R(2020)Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: A two-center descriptive study Lancet Infect Dis 1473-3099 30434-30435

[9] Landi F(2020)Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan China JAMA Intern Med 180 934-943

[10] King CS(2020)Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis Eur Radiol 4 1-10